SCHEMBL25829463

SCHEMBL25829463

Bc1c(B)c(B)c2c(-c3ccc4ccc5ccc(-c6c7c(B)c(B)c(B)c(B)c7c(-c7ccccc7)c7c(B)c(B)c(B)c(B)c67)cc5c4c3)c3c(B)c(B)c(B)c(B)c3c(-c3ccccc3)c2c1B

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.36
ESR2 Q92731 5/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
HSD17B1 P14061 2/20 0.35
CYP2B6 P20813 2/20 0.35
CYP2C19 P33261 2/20 0.35
HSD17B2 P37059 2/20 0.35
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HIF1A Q16665 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PLG P00747 1/20 0.33
PLAU P00749 1/20 0.33
CYP1A1 P04798 1/20 0.32
FYN P06241 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22793715 0.86 ALDH1A1 (0.45) CYP1A2ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL25784040 0.85 HSD17B1 (0.43) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL25784021 0.84 ESR1 (0.44) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL21940406 0.82 ABCG2 (0.45) CYP1A2ALDH1A1HSD17B10CYP1A1FYN
SCHEMBL22420029 0.82 PGR (0.39) ESR1ESR2CDK4CCND1CYP1A2
SCHEMBL25829772 0.82 ESR1 (0.38) ESR1ESR2CDK4CCND1CYP1A2
SCHEMBL24178696 0.82 ESR1 (0.35) ESR1ESR2CDK4CCND1CYP1A2
SCHEMBL25494438 0.81 ABCG2 (0.44) CYP1A2ALDH1A1HSD17B10CYP1A1FYN
SCHEMBL29330267 0.81 HSD17B1 (0.47) ESR1ESR2CYP1A2CYP3A4CYP2D6
SCHEMBL25927503 0.80 ESR1 (0.48) ESR1ESR2CYP1A2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225195-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PERFORMANCE MATERIALS GERMANY GMBH (DE) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225195-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES H1-0, H1-2, H1-4 ESR1 144/4885ESR2 913/4885CDK4 3352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.